{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:25:55Z","timestamp":1775892355294,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alberta Health Services Emergency Strategic Clinical Network","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Edmonton Emergency Physicians Association","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Canadian Research Initiative on Substance Misuse- Prairie Node","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12913-019-4469-3","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T08:04:13Z","timestamp":1567670653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review"],"prefix":"10.1186","volume":"19","author":[{"given":"Daniel C.","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Dabbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Veugelers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-8890","authenticated-orcid":false,"given":"Elaine","family":"Hyshka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"issue":"11","key":"4469_CR1","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/jama.2017.9308","volume":"318","author":"D Dowell","year":"2017","unstructured":"Dowell D, Arias E, Kochanek K, Anderson R, Guy GP Jr, Losby JL, et al. Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015. JAMA. 2017;318(11):1065\u20137.","journal-title":"JAMA."},{"key":"4469_CR2","volume-title":"Community management of opioid overdose","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Community management of opioid overdose. 2014. [cited 2019 May 7]. Available from: \n                    https:\/\/www.who.int\/substance_abuse\/publications\/management _opioid_overdose\/en\/"},{"issue":"2","key":"4469_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMra1202561","volume":"367","author":"W Edward","year":"2012","unstructured":"Edward W. Boyer. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146\u201355.","journal-title":"N Engl J Med"},{"key":"4469_CR4","unstructured":"Minozzi S, Amato L, Davoli M. Preventing fatal overdoses: A systematic review of the effectiveness of take-home naloxone. Eur Monit Centre Drugs Drug Addict. 2015; [cited 2019 May 7]. Available from: \n                    http:\/\/www.emcdda.europa.eu\/publications\/emcdda-papers\/naloxone-effectiveness_en\n                    \n                  ."},{"issue":"3","key":"4469_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","volume":"8","author":"A Clark","year":"2014","unstructured":"Clark A, Wilder C, Winstanley E. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8(3):153\u201363.","journal-title":"J Addict Med"},{"issue":"2","key":"4469_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","volume":"36","author":"SR Mueller","year":"2015","unstructured":"Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36(2):240\u201353.","journal-title":"Subst Abus"},{"key":"4469_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.drugalcdep.2017.06.029","volume":"179","author":"A Siegler","year":"2017","unstructured":"Siegler A, Huxley-Reicher Z, Maldjian L, Jordan R, Oliver C, Jakubowski A, et al. Naloxone use among overdose prevention trainees in new York City: a longitudinal cohort study. Drug Alcohol Depend. 2017;179:124\u201330.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"4469_CR8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.drugpo.2015.09.011","volume":"26","author":"A McAuley","year":"2015","unstructured":"McAuley A, Aucott L, Matheson C. Exploring the life-saving potential of naloxone: a systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users. Int J Drug Policy. 2015;26(12):1183\u20138.","journal-title":"Int J Drug Policy"},{"key":"4469_CR9","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.","journal-title":"BMJ."},{"issue":"6","key":"4469_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.annemergmed.2018.01.052","volume":"71","author":"DE Houry","year":"2018","unstructured":"Houry DE, Haegerich TM, Vivolo-Kantor A. Opportunities for prevention and intervention of opioid overdose in the emergency department. Ann Emerg Med. 2018;71(6):688\u201390.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"4469_CR11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/add.13265","volume":"111","author":"SM Bird","year":"2016","unstructured":"Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland\u2019s national naloxone programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction. 2016;111(5):883\u201391.","journal-title":"Addiction."},{"issue":"1","key":"4469_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajem.2018.05.044","volume":"37","author":"M Verdier","year":"2019","unstructured":"Verdier M, Routsolias JC, Aks SE. Naloxone prescriptions from the emergency department: an initiative in evolution. Am J Emerg Med. 2019;37(1):164\u20135.","journal-title":"Am J Emerg Med"},{"issue":"8","key":"4469_CR13","doi-asserted-by":"publisher","first-page":"619.e2","DOI":"10.1016\/j.annepidem.2015.03.018","volume":"25","author":"JE Brady","year":"2015","unstructured":"Brady JE, DiMaggio CJ, Keyes KM, Doyle JJ, Richardson LD, Li G. Emergency department utilization and subsequent prescription drug overdose death. Ann Epidemiol. 2015;25(8):619.e2.","journal-title":"Ann Epidemiol"},{"key":"4469_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","volume":"162","author":"A Caudarella","year":"2016","unstructured":"Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51\u20135.","journal-title":"Drug Alcohol Depend"},{"key":"4469_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.drugalcdep.2015.05.026","volume":"153","author":"KD Wagner","year":"2015","unstructured":"Wagner KD, Liu L, Davidson PJ, Cuevas-Mota J, Armenta RF, Garfein RS. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: identifying opportunities for intervention. Drug Alcohol Depend. 2015;153:215\u201320.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"4469_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5811\/westjem.2015.2.24909","volume":"16","author":"K Dwyer","year":"2015","unstructured":"Dwyer K, Walley AY, Langlois BK, Mitchell PM, Nelson KP, Cromwell J, et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015;16(3):381\u20134.","journal-title":"West J Emerg Med"},{"issue":"10","key":"4469_CR17","first-page":"38","volume":"97","author":"E Samuels","year":"2014","unstructured":"Samuels E. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths. R I Med J. 2014;97(10):38.","journal-title":"R I Med J"},{"issue":"4","key":"4469_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/acem.12910","volume":"23","author":"EA Samuels","year":"2016","unstructured":"Samuels EA, Dwyer K, Mello MJ, Baird J, Kellogg AR, Bernstein E, et al. Emergency department-based opioid harm reduction: moving physicians from willing to doing. Acad Emerg Med. 2016;23(4):455\u201365.","journal-title":"Acad Emerg Med"},{"issue":"1","key":"4469_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1017\/cem.2017.390","volume":"20","author":"L Lacroix","year":"2018","unstructured":"Lacroix L, Thurgur L, Orkin AM, Perry JJ, Stiell IG. Emergency physicians\u2019 attitudes and perceived barriers to the implementation of take-home naloxone programs in Canadian emergency departments. CJEM. 2018;20(1):46\u201352.","journal-title":"CJEM."},{"issue":"3","key":"4469_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.annemergmed.2016.07.027","volume":"69","author":"A Kestler","year":"2017","unstructured":"Kestler A, Buxton J, Meckling G, Giesler A, Lee M, Fuller K, et al. Factors associated with participation in an emergency department\u2013based take-home naloxone program for at-risk opioid users. Ann Emerg Med. 2017;69(3):340.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"4469_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/0033354916661981","volume":"131","author":"J Ellison","year":"2016","unstructured":"Ellison J, Walley AY, Feldman JA, Bernstein E, Mitchell PM, Koppelman EA, et al. Identifying patients for overdose prevention with ICD-9 classification in the emergency department, Massachusetts, 2013-2014. Public Health Rep. 2016;131(5):671\u20135.","journal-title":"Public Health Rep"},{"issue":"12","key":"4469_CR22","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ajem.2018.03.055","volume":"36","author":"JR Pedigo","year":"2018","unstructured":"Pedigo JR, Seifert CF. Rate of patients at elevated risk of opioid overdose visiting the emergency department. Am J Emerg Med. 2018;36(12):2161\u20135.","journal-title":"Am J Emerg Med"},{"key":"4469_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s13104-016-2268-z","volume":"9","author":"M Drainoni","year":"2016","unstructured":"Drainoni M, Koppelman EA, Feldman JA, Walley AY, Mitchell PM, Ellison J, et al. Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment. BMC Research Notes. 2016;9:465.","journal-title":"BMC Research Notes"},{"issue":"2","key":"4469_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/dar.12894","volume":"38","author":"TJ Holland","year":"2019","unstructured":"Holland TJ, Penm J, Dinh M, Aran S, Chaar B. Emergency department physicians\u2019 and pharmacists\u2019 perspectives on take-home naloxone. Drug Alcohol Rev. 2019;38(2):169\u201376.","journal-title":"Drug Alcohol Rev"},{"key":"4469_CR25","volume-title":"By the heart, by the numbers- the 2016\u20132017 annual report","author":"Royal Alexandra Hospital Foundation","year":"2018","unstructured":"Royal Alexandra Hospital Foundation. By the heart, by the numbers- the 2016\u20132017 annual report. 2018 [cited 2019 May 8]. Available from: \n                    https:\/\/www.royalalex.org\/our-stories\/heart-numbers-2016-17-annual-report\/"},{"key":"4469_CR26","unstructured":"Alberta Health. Opioids and substances of misuse, Alberta report 2019 Q1: Government of Alberta; 2019. [cited 2019 July 24]. Available from: \n                    https:\/\/open.alberta.ca\/dataset\/1cfed7da-2690-42e7-97e9-da175d36f3d5\/resource\/dcb5da36-7511-4cb9-ba11-1a0f065b4d8c\/download\/opioids-substances-misuse-report-2018-q1.pdf"},{"issue":"3","key":"4469_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/02024458-201609000-00005","volume":"6","author":"G Salvalaggio","year":"2016","unstructured":"Salvalaggio G, Dong K, Hyshka E, Nixone L, Lavergne K, Nichols J, et al. Enhanced multidisciplinary care for inner city patients with high acute care use: study protocol. Can J Addict. 2016;6(3):34\u201341.","journal-title":"Can J Addict"},{"issue":"3","key":"4469_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochemia medica. 2012;22(3):276\u201382.","journal-title":"Biochemia medica"},{"issue":"5","key":"4469_CR29","first-page":"436","volume":"16","author":"D Briggs","year":"2009","unstructured":"Briggs D, Rhodes T, Marks D, Kimber J, Holloway G, Jones S. Injecting drug use and unstable housing: scope for structural interventions in harm reduction. Drugs: Education, Prevention and Policy. 2009;16(5):436\u201350.","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"1","key":"4469_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.drugpo.2006.11.019","volume":"18","author":"W Small","year":"2007","unstructured":"Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Policy. 2007;18(1):27\u201336.","journal-title":"Int J Drug Policy"},{"issue":"7872","key":"4469_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","volume":"2","author":"G Teasdale","year":"1974","unstructured":"Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81\u20134.","journal-title":"Lancet."},{"key":"4469_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. Third ed. Hoboken: Wiley; 2013.","edition":"Third ed."},{"key":"4469_CR33","volume-title":"STATA Multiple-Imputation Reference Manual, Release 13","author":"StataCorp","year":"2013","unstructured":"StataCorp. STATA Multiple-Imputation Reference Manual, Release 13. 2013; Available from: \n                    https:\/\/www.stata.com\/manuals13\/mi.pdf\n                    \n                  ."},{"issue":"11","key":"4469_CR34","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.ajem.2018.03.036","volume":"36","author":"K Barbour","year":"2018","unstructured":"Barbour K, McQuade M, Somasundaram S, Chakravarthy B. Emergency physician resistance to a take-home naloxone program led by community harm reductionists. Am J Emerg Med. 2018;36(11):2110\u20132.","journal-title":"Am J Emerg Med"},{"key":"4469_CR35","volume-title":"Fentanyl-detected illicit drug overdose deaths, January 1, 2009 to January 31, 2019. Government of British Columbia Ministry of Public Safety and Solicitor General","author":"British Columbia Coroners Service","year":"2019","unstructured":"British Columbia Coroners Service. Fentanyl-detected illicit drug overdose deaths, January 1, 2009 to January 31, 2019. Government of British Columbia Ministry of Public Safety and Solicitor General; 2019 [cited 2019 July 24]. Available from: \n                    https:\/\/www2.gov.bc.ca\/assets\/gov\/birth-adoption-death-marriage-and-divorce\/deaths\/coroners-service\/statistical\/illicit-drug.pdf"},{"key":"4469_CR36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.drugalcdep.2017.05.001","volume":"178","author":"R McDonald","year":"2017","unstructured":"McDonald R, Campbell ND, Strang J. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-conception and maturation. Drug Alcohol Depend. 2017;178:176\u201387.","journal-title":"Drug Alcohol Depend"},{"issue":"7044","key":"4469_CR37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/bmj.312.7044.1435","volume":"312","author":"J Strang","year":"1996","unstructured":"Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take-home naloxone. BMJ. 1996;312(7044):1435\u20136.","journal-title":"BMJ."},{"issue":"12","key":"4469_CR38","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s11606-015-3394-3","volume":"30","author":"IA Binswanger","year":"2015","unstructured":"Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff. J Gen Intern Med. 2015;30(12):1837\u201344.","journal-title":"J Gen Intern Med"},{"key":"4469_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ypmed.2018.06.005","volume":"114","author":"E Behar","year":"2018","unstructured":"Behar E, Bagnulo R, Coffin PO. Acceptability and feasibility of naloxone prescribing in primary care settings: a systematic review. Prev Med. 2018;114:79\u201387.","journal-title":"Prev Med"},{"issue":"5","key":"4469_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1370\/afm.1972","volume":"14","author":"E Behar","year":"2016","unstructured":"Behar E, Rowe C, Santos GM, Murphy S, Coffin PO. Primary care patient experience with naloxone prescription. Ann Fam Med. 2016;14(5):431\u20136.","journal-title":"Ann Fam Med"},{"issue":"3","key":"4469_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/pm\/pnx021","volume":"19","author":"S Nielsen","year":"2018","unstructured":"Nielsen S, Peacock A, Lintzeris N, Bruno R, Larance B, Degenhardt L. Knowledge of opioid overdose and attitudes to supply of take-home naloxone among people with chronic noncancer pain prescribed opioids. Pain Med. 2018;19(3):533\u201340.","journal-title":"Pain Med"},{"issue":"4","key":"4469_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7326\/M15-2771","volume":"165","author":"PO Coffin","year":"2016","unstructured":"Coffin PO, Behar E, Rowe C, Santos G, Coffa D, Bald M, et al. Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain. Ann Intern Med. 2016;165(4):245.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4469_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/2042098617744161","volume":"9","author":"R Rzasa Lynn","year":"2018","unstructured":"Rzasa Lynn R, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018;9(1):63\u201388.","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"4469_CR44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1017\/cem.2018.368","volume":"21","author":"A Kestler","year":"2019","unstructured":"Kestler A, Giesler A, Buxton J, Meckling G, Lee M, Hunte G, et al. Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone. CJEM. 2019;21(2):226\u201334.","journal-title":"CJEM."},{"key":"4469_CR45","doi-asserted-by":"publisher","first-page":"h2698","DOI":"10.1136\/bmj.h2698","volume":"350","author":"TW Park","year":"2015","unstructured":"Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698.","journal-title":"BMJ"},{"key":"4469_CR46","doi-asserted-by":"publisher","first-page":"j760","DOI":"10.1136\/bmj.j760","volume":"356","author":"EC Sun","year":"2017","unstructured":"Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017;356:j760.","journal-title":"BMJ"},{"issue":"1","key":"4469_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","volume":"65","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1\u201349.","journal-title":"MMWR Recomm Rep"},{"key":"4469_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","volume":"190","author":"KW Tupper","year":"2018","unstructured":"Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"4469_CR49","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jemermed.2018.12.029","volume":"56","author":"J Devries","year":"2019","unstructured":"Devries J, Rafie S, Ajayi TA, Kreshak A, Edmonds KP. Results of a naloxone screening quality-improvement project in an academic emergency department. J Emerg Med. 2019;56(4):378\u201385.","journal-title":"J Emerg Med"},{"issue":"9","key":"4469_CR50","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/add.14635","volume":"114","author":"R Marino","year":"2019","unstructured":"Marino R, Landau A, Lynch M, Callaway C, Suffoletto B. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose? Addiction. 2019;114(9):1575\u201381.","journal-title":"Addiction"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-019-4469-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-019-4469-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-019-4469-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T23:20:06Z","timestamp":1599175206000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-019-4469-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1186\/s12913-019-4469-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"11 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our research protocol received ethics approval from the University of Alberta\u2019s Health Research Ethics Board. The Research Ethics Board agreed that it was not necessary or feasible to obtain individual consent because our study used secondary use of extracted and anonymized administrative health data. Therefore, there was no contact with human subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"632"}}